Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify ...

A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.

Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...

Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...

A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...

In a study published today, Friday, February 13, 2026, in the journal Nature Aging, researchers show that blood-based ...

Heather Quintana Suchan, a mother living with stage 4 lung cancer, is using her platform to encourage other patients to pursue biomarker testing and genomic profiling early in the diagnostic process, ...

In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...

Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...

Mississippi's House Bill 565, known as Jill's Law, aims to provide coverage for biomarker testing to improve cancer treatment ...

State lawmakers are looking at a new bill that would require Medicaid and private insurance providers to cover biomarker testing for cancer patients. Biomarker testing can identify what type of ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called ...